Leadership & Pay ·
Appoints Ansuman Satpathy and Joseph Gilliam to Board of Directors
TXG10x Genomics, Inc.
10x Genomics appointed Ansuman Satpathy and Joseph Gilliam as Class III directors effective October 28, 2026. Dr. Satpathy brings expertise in genomics and immunology from Stanford University and life sciences ventures, while Mr. Gilliam offers senior management experience from Glaukos Corporation and healthcare investment banking background at JPMorgan Chase. Both received standard non-employee director compensation packages including cash retainers and restricted stock units. Mr. Gilliam was subsequently appointed Chair of the Audit Committee on October 30, 2026. The company develops single-cell genomics technologies for life science research.